Intellectual Property

  • July 21, 2026

    Atty Immunity Should Cut Firm From Fee Suit, Judge Says

    A Texas federal judge has recommended letting California law firm Bartko Pavia out of a lawsuit brought by litigation boutique Williams Simons & Landis PC over alleged unpaid legal fees, saying attorney immunity shields the California firm.

  • July 21, 2026

    India-Based AI Founder Says Colo. Court Lacks Jurisdiction

    The former chief business officer and founder of an AI mapping company accused of copying thousands of its rivals' maps told a Colorado federal judge Monday that the court has no jurisdiction over him and that the claims against him must be dismissed.

  • July 21, 2026

    Invisalign Maker Align Keeps PTAB Wins At Fed. Circ.

    The Patent Trial and Appeal Board properly invalidated claims in two Dental Monitoring SAS orthodontia patents, the Federal Circuit affirmed Tuesday.

  • July 21, 2026

    Google's Copyright Claims Over Scraping Tossed, For Now

    A California federal judge has dismissed Google's complaint accusing data-scraping company SerpApi of bypassing technological safeguards to copy and resell the tech giant's search results, ruling that Google did not plausibly allege its anti-scraping system operated with the authority of copyright owners whose content appeared in those results.

  • July 21, 2026

    Acer Can't Escape Ericsson Dispute Over 4G, 5G Patents

    A Delaware federal judge won't throw out Ericsson's suit seeking a finding it didn't infringe Acer Inc. patents covering 4G, LTE and 5G wireless standards, despite Acer filing litigation first in Texas accusing Ericsson's customers of infringement.

  • July 21, 2026

    Thermo Fisher Says TRO Needed To Protect $8.9B Deal

    A Delaware Chancery Court judge said Tuesday he is still weighing whether to temporarily block a former Thermo Fisher Scientific Inc. executive from joining Fortrea Holdings Inc., signaling that the dispute turns on difficult questions about the scope of restrictive covenants while cautioning the parties not to assume how he will rule.

  • July 21, 2026

    Mother Of Musk's Child Asks Texas Court To Toss XAI Suit

    The mother of one of Elon Musk's children has asked a Texas federal court to toss a suit brought by Musk's artificial intelligence company, xAI, that alleges breach of contract, telling the court that xAI's actions constituted "a race to the courthouse dressed up as a lawsuit."

  • July 21, 2026

    Novo's False Ad Suit Against Eli Lilly Ramps Up GLP-1 Rivalry

    Pharmaceutical giant Novo Nordisk Inc. slapped rival Eli Lilly & Co. with a false advertising suit in New Jersey federal court Tuesday, calling a marketing campaign for the rival's weight loss drugs "deceptive" for "withholding critical scientific evidence" about newer GLP-1 formulations.

  • July 21, 2026

    Squires Pressed On 'Board Of Peace' TM Apps He Withdrew

    A Maryland congressman has asked U.S. Patent and Trademark Office Director John Squires for more information about what he said was his "baffling and legally dubious" push to secure trademark protections for President Donald Trump's "Board of Peace."

  • July 21, 2026

    Canon Notches Another Fed. Circ. Win In Inkjet Patent Fight

    The Federal Circuit on Tuesday declined to reboot claims in a Slingshot Printing patent covering a printhead for an inkjet printer challenged by Canon at the Patent Trial and Appeal Board, less than a week after the appeals court backed decisions invalidating claims in three similar patents.

  • July 21, 2026

    Fed. Circ. Restarts Treadmill Patent Infringement Case

    The Federal Circuit on Tuesday revived a case in which treadmill maker Woodway USA Inc. sued exercise equipment company Lifecore Fitness Inc., saying Lifecore was granted a win based on an overly narrow claim construction.

  • July 21, 2026

    Wyeth's Patent Loss Has Attys Focusing On Dosage

    The Federal Circuit's holding that a Pfizer unit's cancer treatment patents are invalid highlights the risk of including dosages in patents without sufficient proof that those dosages work, attorneys say.

  • July 21, 2026

    New Head Of US International Trade Commission Selected

    President Donald Trump has tapped the newest member of the U.S. International Trade Commission to serve as its chair, the ITC announced Tuesday.

  • July 21, 2026

    Centripetal IP Survives Fed. Circ. Despite 'Ghost In The Room'

    A Federal Circuit panel on Tuesday backed a Patent Trial and Appeal Board decision that declined to strike some claims in a cybersecurity patent owned by Centripetal Networks LLC, even if a "ghost in the room" suggests that it's preserving unpatentable claims.

  • July 21, 2026

    Apple's Bid To Invalidate Speech Patent Revived On Appeal

    The Federal Circuit on Tuesday gave Apple Inc. another opportunity to show that claims in a Zentian Ltd. speech recognition patent are invalid, faulting the Patent Trial and Appeal Board's decision to uphold the patent, which is at issue in a California infringement suit.

  • July 21, 2026

    7th Circ. Probes Offset Restitution In Hytera-Motorola Dispute

    Seventh Circuit judges appeared amenable Tuesday to Motorola's argument that an Illinois federal judge wrongly refused to order Hytera to pay restitution for stealing trade secrets and improperly treated Hytera's payments in parallel civil litigation as offsets in the criminal case, effectively nullifying Motorola's punitive damages award.

  • July 21, 2026

    Resume Builder Defends Antitrust Case Against Rival

    Rocket Resume Inc. is defending its antitrust case in California federal court accusing Bold Ltd., the owner of Monster and CareerBuilder, of monopolizing the U.S. market for online resume-building platforms.

  • July 21, 2026

    Baker McKenzie Hires Life Sciences, IP Attys In DC, NY

    Baker McKenzie has hired two attorneys, in Washington, D.C., and New York, who focus their practices on life sciences transactional matters and intellectual property issues, the firm announced Tuesday.

  • July 21, 2026

    Boehringer Alleges United Therapeutics Poached Staff, Secrets

    Boehringer Ingelheim Pharmaceuticals Inc. is suing United Therapeutics Corp. in Delaware Chancery Court, alleging it recruited more than 20 members of Boehringer's specialized interstitial lung disease sales team to obtain confidential business information before launching a competing drug.

  • July 21, 2026

    DirecTV Sues Over Va. Fraud Scheme

    DirecTV has filed suit against a Virginia man and a group of companies, alleging that they engaged in a scheme to defraud DirecTV customers.

  • July 21, 2026

    College Advising Co. Drops Contract Row With Ex-Franchisee

    A college consulting company has dropped its lawsuit accusing a former franchisee of filching its proprietary methods and starting a new venture, North Carolina federal court records show.

  • July 20, 2026

    Moderna Hits CureVac With Countersuit In COVID Vax Fight

    Moderna has filed a countersuit in Delaware federal court against a BioNTech subsidiary's claims that Moderna's COVID-19 vaccine infringed several patents, saying the rival biotech company was trying to "take credit" for Moderna's own innovations in mRNA vaccines.

  • July 20, 2026

    Google Data Sharing With Temu Violates DOJ Rule, Suit Says

    Google shares internet users' sensitive information with Chinese e-commerce giant Temu and a technology firm the Pentagon calls a "Chinese military company," violating a U.S. Department of Justice rule preventing the bulk transmission of data to "countries of concern," according to a proposed class action in California federal court.

  • July 20, 2026

    Cox, Insurers Battle For Early Win In Media Coverage Suit

    Cox Enterprises and two insurers competed Monday for an early win in the company's suit alleging it was wrongly denied coverage for more than $15 million in expenses spent defending, and ultimately settling, a lawsuit that aimed to hold the internet service provider liable for users' illegal downloads.

  • July 20, 2026

    Anthropic's $1.5B Copyright Deal With Authors Gets Final OK

    A California federal judge on Monday gave final approval to Anthropic's $1.5 billion settlement resolving authors' allegations the artificial intelligence company pirated their work to train its flagship product, Claude, setting aside roughly $101.5 million in attorney fees for class counsel.

Expert Analysis

  • 2 AI Snafus Show Why Attys Can't Outsource Judgment

    Author Photo

    The recent incident involving Sullivan & Cromwell where citations in a filed motion were fabricated by artificial intelligence, as well as a punitive ruling from the Sixth Circuit in U.S. v. Farris, demonstrate that the obligation to supervise AI has belonged and always will belong to lawyers, says John Powell at the Kentucky School Boards Association.

  • Opinion

    Congress Must Repair USPTO's Inter Partes Review Process

    Author Photo

    To challenge recent changes to the inter partes review process issued by the U.S. Patent and Trademark Office, Congress must establish clear statutory guardrails, transparency and meaningful judicial review so that questionable patents receive proper scrutiny, say Sean Tu at the University of Alabama, Arti Rai at Duke University and Aaron Kesselheim at Harvard.

  • Series

    Playing Magic: The Gathering Makes Me A Better Lawyer

    Author Photo

    The competitive card game Magic: The Gathering offers me a training ground for the strategic thinking skills crucial to litigation, challenging me to adapt to oft-updated rules, analyze text as complicated as any statute and anticipate my opponent’s next moves, says Christopher Smith at Lash Goldberg.

  • Fed. Circ. In March: IPR And The Limits Of Retroactivity

    Author Photo

    The Federal Circuit recently ruled in Implicit v. Sonos that even though the clever retroactive correction of two invalidated patents theoretically should have changed the outcome of the inter partes review, the patentee had forfeited the right to rely on the correction — which is interesting for several reasons, say attorneys at Knobbe Martens.

  • Improving Well-Being In Law, 10 Years After Landmark Study

    Author Photo

    An important 2016 study revealed significant substance abuse and mental health issues among lawyers, and while the findings helped normalize the conversation around these topics, a decade later, structural change is still needed, says Denise Robinson at PLI.

  • Sizing Up The 3-Way Battle For 'Iceman' IP Rights

    Author Photo

    A complex intellectual property conflict is unfolding between athletes Caleb Williams, George Gervin and Chuck Liddell — each of whom has different, credible claims to the "Iceman" nickname and associated trademark rights, say attorneys at Foley & Lardner.

  • Opinion

    Proposed Pro Codes Act Raises Constitutional Concerns

    Author Photo

    If passed, the Pro Codes Act being considered in the U.S. House of Representatives would fundamentally alter how technical standards are treated under U.S. law, and potentially conflict with the Fifth Amendment's takings clause, says Paul Taylor at George Mason University.

  • How The Coming Months Will Shape State Drug Price Boards

    Author Photo

    The future of state prescription drug affordability boards may be determined in the next few months, between an upcoming court decision in a challenge against state authority to set drug prices, and pending state decisions about whether to use federal Medicare maximum fair prices as reference, say Michael Kolber, Steven Chen and Kelechi Ezealaji at Manatt.

  • High Court 'Skinny Label' Case Will Matter To Tech Litigators

    Author Photo

    Hikma v. Amarin, set for oral argument in the U.S. Supreme Court on Wednesday, has potential to affect not just generic drug label-based evidence in patent cases, but also how technology inducement cases are presented and proven, says attorney Abdul Abdullahi.

  • Opinion

    New Legislation May Be Necessary To Fix Flawed Cox Ruling

    Author Photo

    The U.S. Supreme Court's opinion in Cox v. Sony erroneously limited the doctrine of contributory copyright infringement and effectively eliminated such liability for internet service providers, and the most viable option to remedy the damage is to codify the pre-Cox common law of contributory copyright infringement, says Michael Cicero at Mavacy.

  • Reel Justice: 'No Other Choice' And Moral Rationalization

    Author Photo

    In the satirical thriller "No Other Choice," the main character rationalizes his decision to kill business competitors by creating a narrative of necessity, illustrating for attorneys the dangers of treating strategic litigation decisions as inevitabilities rather than choices, says Veronica Finkelstein at Wilmington University.

  • 5 Trial Lessons You Learn By Losing

    Author Photo

    Exploring insights that are usually gained only after trial loss can expose the gaps between what we intend to communicate and what lands with the fact-finder, including why being right isn't always a win and how winning a cross‑examination can help you lose your case, says Allison Rocker at Baker & McKenzie.

  • Fed. Circ.'s Christmas Tree Verdict Presents Patent Suit Tips

    Author Photo

    The Federal Circuit's recent decision in Willis Electric v. Polygroup, upholding a $42.5 million verdict for infringing an artificial prelit Christmas tree patent, underscores important strategies and considerations for both patent owners and accused infringers when dealing with obviousness challenges and damages calculations, say attorneys at BCLP.

  • Series

    Officiating Football Makes Me A Better Lawyer

    Author Photo

    Though they may seem to have little in common, officiating football has sharpened many of the same skills that define effective lawyering in management-side labor and employment: preparation, judgment, composure, credibility and ability to make difficult decisions in real time, says Josh Nadreau at Fisher Phillips.

  • Cos. Must Update Protocols To Protect Trade Secrets From AI

    Author Photo

    A recent data exposure incident at Meta shows how artificial intelligence agents present a novel trade secret threat, which should be addressed by a proactive overhaul of companies' reasonable-measures framework, says Eric Ostroff at Meland Budwick.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.